PREFER: Open science, open access
The PREFER project is committed to open science. We have promised our funders, the Innovative Medicines Initiative, to ensure all our publications are available to those who do not have, or cannot afford, subscritpions to scientific journals. This is made possible through postprint publishing in the Uppsala University library's DiVA database, also known as green open access.
Open access publication is an important part of open science. The PREFER project has decided to use the "green" route for most of our publications, making postprints available in a public database, after the journal's embarbo ends. This is also known as "parallel publishing" and means that the authors' version (before the journal layout) becomes available after a fixed period of time (that varies between journals).
To date, two publications have been made available using the green route:
de Bekker-Grob, Esther W.; Juhaeri, Juhaeri; Kihlbom, Ulrik; Levitan, Bennett et al., Giving patients' preferences a voice in the medical product lifecycle: why, when and how?: The public-private PREFER project: Work package 2, ISPOR Value & Outcomes Spotlight, p. 19 19-21 21, 2018.
de Bekker-Grob, Esther; Berlin, Conny; Levitan, Bennet; Raza, Karim et al., Giving Patients’ Preferences a Voice in Medical Treatment Life Cycle: The PREFER Public–Private Project, Patient, p. 263-266, 2017.
This is the first step to honouring our commitment to open access publication. In the future, PREFER will ensure that all of our publications are made available, either through the journal (aka "gold" open access) or through the DiVA repository.
By Josepine Fernow